https://assets.capyfin.com/instruments/678fdc13234e27009c5d5809.png avatar
Walgreens
🇺🇸 NASDAQ:WBA
View Company
OverviewEarningsDividends
•
Feb 28, 2022

Walgreens Q2 2022 Earnings Report

Walgreens reported strong Q2 2022 results with increased sales and earnings, driven by COVID-19 vaccinations and testing, U.S. retail comparable sales, and Boots UK retail comparable sales.

Key Takeaways

Walgreens Boots Alliance reported a 3.0% increase in sales from continuing operations to $33.8 billion and an adjusted EPS increase of 25.9% to $1.59 in the second quarter of fiscal 2022. The company is maintaining its full-year adjusted EPS guidance of low-single digit growth.

Second quarter EPS from continuing operations was $1.02, while adjusted EPS increased 25.9 percent to $1.59.

Second quarter sales from continuing operations increased 3.0 percent to $33.8 billion.

Second quarter operating income from continuing operations increased to $1.2 billion.

Walgreens Health pro forma sales up 128 percent compared to year-ago standalone results.

Total Revenue
$33.8B
Previous year: $32.8B
+3.0%
EPS
$1.59
Previous year: $1.26
+26.2%
Gross Profit
$7.71B
Previous year: $6.78B
+13.7%
Cash and Equivalents
$1.89B
Previous year: $1.03B
+83.2%
Free Cash Flow
$669M
Previous year: $1.1B
-39.2%
Total Assets
$92.7B
Previous year: $90.9B
+1.9%

Walgreens

Walgreens

Walgreens Revenue by Segment

Forward Guidance

Maintaining full year adjusted EPS guidance of low-single digit growth

Revenue & Expenses

Visualization of income flow from segment revenue to net income

Company Overview

Full financial data and analysis

View Walgreens